Publications by authors named "Y Lotan"

Claim this Profile
I
Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group.
Roger Li, Patrick J Hensley, Marko Babjuk, Laura Bukavina, Sarah P Psutka, Yair Lotan

Eur Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidance for avoiding patient pain and discomfort during transurethral cystoscopy.
Avani P Desai, Angela B Smith, Yair Lotan

Expert Rev Med Devices· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Intravesical Instillations on Quality of Life in Patients with Non-Muscle-Invasive Bladder Cancer: A Systematic Review.
Ingolf Griebsch, Sunil Shrestha, Yair Lotan, Chi-Fai Ng, Andrew Bottomley

Oncol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unlocking the potential of long non-coding RNAs in bladder cancer.
Yoran L Tomassen, Ewan A Gibb, Yair Lotan, Joep J de Jong

Expert Rev Mol Diagn· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is histological grade a useful parameter in muscle-invasive urothelial bladder cancer? Results from a multicenter study on the impact of different grading systems on disease-free survival after upfront radical cystectomy.
Emily Rinderknecht, Francesco Claps, Peter J Bostrom, Shahrokh F Shariat, Yann Neuzillet, Yair Lotan

World J Urol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis